Search Results - "Domènech, E."

Editorial: faecal incontinence—the hidden burden of inflammatory bowel diseases by Cañete, F., Domènech, E.

“…Linked content This article is linked to Vollebregt et al papers. To view these articles visit https://doi.org/10.1111/apt.14599 and…”
Get full text

Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease by Casanova, M J, Chaparro, M, Domènech, E, Barreiro-de Acosta, M, Bermejo, F, Iglesias, E, Gomollón, F, Rodrigo, L, Calvet, X, Esteve, M, García-Planella, E, García-López, S, Taxonera, C, Calvo, M, López, M, Ginard, D, Gómez-García, M, Garrido, E, Pérez-Calle, J L, Beltrán, B, Piqueras, M, Saro, C, Botella, B, Dueñas, C, Ponferrada, A, Mañosa, M, García-Sánchez, V, Maté, J, Gisbert, J P

“…The safety of thiopurines and anti-tumor necrosis factor-α (TNF-α) drugs during pregnancy remains controversial, as the experience with these drugs in this…”
Get full text

Letter: phenotype and natural history of elderly onset inflammatory bowel disease—Authors’ reply by Mañosa, M., Domènech, E.

“…Linked Content This article is linked to Mañosa et al and Everhov et al papers. To view these articles visit https://doi.org/10.1111/apt.14494 and…”
Get full text

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease by Rahier, J F, Ben-Horin, S, Chowers, Y, Conlon, C, De Munter, P, D'Haens, G, Domènech, E, Eliakim, R, Eser, A, Frater, J, Gassull, M, Giladi, M, Kaser, A, Lémann, M, Moreels, T, Moschen, A, Pollok, R, Reinisch, W, Schunter, M, Stange, E F, Tilg, H, Van Assche, G, Viget, N, Vucelic, B, Walsh, A, Weiss, G, Yazdanpanah, Y, Zabana, Y, Travis, S P L, Colombel, J F

Get full text

Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study by Ordás, I, Domènech, E, Mañosa, M, García-Sánchez, V, Iglesias-Flores, E, Peñalva, M, Cañas-Ventura, A, Merino, O, Fernández-Bañares, F, Gomollón, F, Vera, M, Gutiérrez, A, Garcia-Planella, E, Chaparro, M, Aguas, M, Gento, E, Muñoz, F, Aguirresarobe, M, Muñoz, C, Fernández, L, Calvet, X, Jiménez, C E, Montoro, M A, Mir, A, De Castro, M L, García-Sepulcre, M F, Bermejo, F, Panés, J, Esteve, M

“…To determine the efficacy and safety of cyclosporine (CyA) in a large national registry-based population of patients with steroid-refractory (SR) acute severe…”
Get full text

Editorial: therapeutic drug monitoring for anti‐TNF agents—has it all been said? by Domènech, E., Cañete, F., Mañosa, M.

“…Linked Content This article is linked to Nakase and Nakase et al papers. To view these articles visit https://doi.org/10.1111/apt.14365 and…”
Get full text

Phenotype and natural history of elderly onset inflammatory bowel disease: a multicentre, case‐control study by Mañosa, M., Calafat, M., Francisco, R., García, C., Casanova, M. J., Huelín, P., Calvo, M., Tosca, J., Fernández‐Salazar, L., Arajol, C., Zabana, Y., Bastida, G., Hinojosa, J., Márquez, L., Barreiro‐de‐Acosta, M., Calvet, X., Monfort, D., Gómez‐Garcia, M. R., Rodríguez, E., Huguet, J. M., Rojas‐Feria, M., Hervias, D., Atienza, R., Busquets, D., Zapata, E., Dueñas, C., Charro, M., Martínez‐Cerezo, F. J., Plaza, R., Vázquez, J. M., Gisbert, J. P., Cañete, F., Cabré, E., Domènech, E., Arajol, Clàudia, Atienza, Ramón, Barreiro‐de‐Acosta, Manuel, Bastida, Guillermo, Busquets, David, Calafat, Margalida, Calvet, Xavier, Calvo, Marta, Cabré, Eduard, Cañete, Fiorella, Casanova, Mª José, Charro, Mara, Dueñas, Carmen, Domènech, Eugeni, Francisco, Ruth, Fernández‐Salazar, Luis, García, Carmen, Gómez‐Garcia, María Rosario, Hervias, Daniel, Hinojosa, Joaquín, Huelín, Patricia, Huguet, José Mª, Mañosa, Míriam, Márquez, Lucía, Martínez‐Cerezo, Francisco J., Monfort, David, Gisbert, Javier P., Plaza, Rocío, Rodríguez, Esther, Rojas‐Feria, María, Tosca, Joan, Vázquez, Juan M., Zabana, Yamile, Zapata, Eva

“…Summary Background Onset during old age has been reported in upto 10% of total cases of inflammatory bowel disease (IBD). Aim To evaluate phenotypic…”
Get full text

Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry by Chaparro, María, Ramas, M, Benítez, J M, López-García, A, Juan, A, Guardiola, J, Mínguez, M, Calvet, X, Márquez, L, Fernández Salazar, L I, Bujanda, L, García, C, Zabana, Y, Lorente, R, Barrio, J, Hinojosa, E, Iborra, M, Cajal, M Domínguez, Van Domselaar, M, García-Sepulcre, M F, Gomollón, F, Piqueras, M, Alcaín, G, García-Sánchez, V, Panés, J, Domènech, E, García-Esquinas, E, Rodríguez-Artalejo, F, Gisbert, J P

“…The objective of this study was (a) To know the prevalence and distribution of extracolonic cancer (EC) in patients with inflammatory bowel disease (IBD); (b)…”
Get full text

Immunomodulatory Therapy Does Not Increase the Risk of Cancer in Persons With Inflammatory Bowel Disease and a History of Extracolonic Cancers by Mañosa, Míriam, Chaparro, M, Juan, A, Aràjol, C, Alfaro, I, Mínguez, M, Velayos, B, Benítez, J M, Mesonero, F, Sicilia, B, Zabana, Y, Villoria, A, Gisbert, J P, Domènech, E

“…Immunosuppressant therapies (IMTs; thiopurines, anti-tumor necrosis factor agents) may influence the immunologic control of cancer and might facilitate the…”
Get full text

ANP32E, a Protein Involved in Steroid-Refractoriness in Ulcerative Colitis, Identified by a Systems Biology Approach by Lorén, V, Garcia-Jaraquemada, A, Naves, J E, Carmona, X, Mañosa, M, Aransay, A M, Lavin, J L, Sánchez, I, Cabré, E, Manyé, J, Domènech, E

“…Abstract Background and Aims Steroid-refractoriness is a common and unpredictable phenomenon in ulcerative colitis [UC], but there are no conclusive studies on…”
Get full text

Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA Registry by Ordás, I, Domènech, E, Mañosa, M, García-Sánchez, V, Iglesias-Flores, E, Rodríguez-Moranta, F, Márquez, L, Merino, O, Fernández-Bañares, F, Gomollón, F, Vera, M, Gutiérrez, A, LLaó, J, Gisbert, J P, Aguas, M, Arias, L, Rodríguez-Lago, I, Muñoz, C, Alcaide, N, Calvet, X, Rodríguez, C, Montoro, M A, García, S, De Castro, M L, Piqueras, M, Pareja, L, Ribes, J, Panés, J, Esteve, M

“…Despite the increased use of rescue medical therapies for steroid refractory acute severe ulcerative colitis, mortality related to this entity still remains…”
Get full text

Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study by Casanova, M J, Chaparro, M, García-Sánchez, V, Nantes, O, Leo, E, Rojas-Feria, M, Jauregui-Amezaga, A, García-López, S, Huguet, J M, Arguelles-Arias, F, Aicart, M, Marín-Jiménez, I, Gómez-García, M, Muñoz, F, Esteve, M, Bujanda, L, Cortés, X, Tosca, J, Pineda, J R, Mañosa, M, Llaó, J, Guardiola, J, Pérez-Martínez, I, Muñoz, C, González-Lama, Y, Hinojosa, J, Vázquez, J M, Martinez-Montiel, M P, Rodríguez, G E, Pajares, R, García-Sepulcre, M F, Hernández-Martínez, A, Pérez-Calle, J L, Beltrán, B, Busquets, D, Ramos, L, Bermejo, F, Barrio, J, Barreiro-de Acosta, M, Roncedo, O, Calvet, X, Hervías, D, Gomollón, F, Domínguez-Antonaya, M, Alcaín, G, Sicilia, B, Dueñas, C, Gutiérrez, A, Lorente-Poyatos, R, Domínguez, M, Khorrami, S, Muñoz, C, Taxonera, C, Rodríguez-Pérez, A, Ponferrada, A, Van Domselaar, M, Arias-Rivera, M L, Merino, O, Castro, E, Marrero, J M, Martín-Arranz, M, Botella, B, Fernández-Salazar, L, Monfort, D, Opio, V, García-Herola, A, Menacho, M, Ramírez-de la Piscina, P, Ceballos, D, Almela, P, Navarro-Llavat, M, Robles-Alonso, V, Vega-López, A B, Moraleja, I, Novella, M T, Castaño-Milla, C, Sánchez-Torres, A, Benítez, J M, Rodríguez, C, Castro, L, Garrido, E, Domènech, E, García-Planella, E, Gisbert, J P

“…The aims of this study were to assess the risk of relapse after discontinuation of anti-tumor necrosis factor (anti-TNF) drugs in patients with inflammatory…”
Get full text

Real‐world short‐term effectiveness of ustekinumab in 305 patients with Crohn’s disease: results from the ENEIDA registry by Iborra, M., Beltrán, B., Fernández‐Clotet, A., Gutiérrez, A., Antolín, B., Huguet, J.M., De Francisco, R., Merino, O., Carpio, D., García‐López, S., Mesonero, F., Navarro, P., Ferreiro‐Iglesias, R., Carbajo, A.Y., Rivero, M., Gisbert, J.P., Piñero‐Pérez, M.C., Monfort, D., Bujanda, L., García‐Sepulcre, M.F., Martín‐Cardona, A., Cañete, F., Taxonera, C., Domènech, E., Nos, P., Sierra‐Ausín, M., Ferrer‐Rosique, J.A., Martín‐Arranz, M.D., González‐Muñoza, C., Manceñido, N., Rodriguez‐Lago, I., Benítez, J.M., Forés‐Bosch, A., Navarro‐Llavat, M., Calafat, M., Madrigal‐Domínguez, R.E., Arroyo, M., Busquets, D., Lorente, R., Sainz‐Arnau, E., Hernández‐Camba, A., Morales‐Alvarado, V.J., Paredes, J.M., Van Domselaar, M., Hervás, D., Cañada‐Martínez, A., Castro‐Poceiro, J., Cameo‐Lorenzo, J., Fernández‐Salazar, L., Riestra, S., Casas‐Deza, D., Tosca, J., Barrio, J., García, M.J., Chaparro, M.

“…Summary Background There are limited data of ustekinumab administered according to the doses recommended in the UNITI studies. Aim To assess the real‐world,…”
Get full text

Safety and effectiveness of direct-acting antiviral drugs in the treatment of hepatitis C in patients with inflammatory bowel disease by Martin-Cardona, A., Horta, D., Florez-Diez, P., Vela, M., Mesonero, F., Ramos Belinchón, C., García, M.J., Masnou, H., de la Peña-Negro, L., Suarez Ferrer, C., Casanova, M.J., Durán, M. Ortiz, Peña, E., Calvet, X., Fernández-Prada, S.J., González-Muñoza, C., Piqueras, M., Rodríguez-Lago, I., Sainz, E., Bas-Cutrina, F., Mancediño Marcos, N., Ojeda, A., Orts, B., Sicilia, B., García, A. Castaño, Domènech, E., Esteve, M.

“…Hepatitis C virus (HCV) management in Inflammatory Bowel Disease (IBD) is uncertain. The ECCO guidelines 2021 recommended HCV treatment but warn about the risk…”
Get full text

A real-life overview of a hematopoietic cell transplant program throughout a four-year period, including prospective registry, exclusion causes and final donor selection by Parody, R., Sánchez-Ortega, I., Mussetti, A., Patiño, B., Arnan, M., Pomares, H., González-Barca, E., Mercadal, S., Boqué, C., Maluquer, C., Carro, I., Peña, M., Clapés, V., Verdesoto, S., Bustamante, G., Oliveira, AC, Baca, C., Cabezudo, E., Talarn, C., Escoda, L., Ortega, S., García, N., Isabel González-Medina, M., Sánchez-Salmerón, Mar, Fusté, C., Villa, J., Carreras, E., Domingo-Domènech, E., Sureda, A.

“…Traceability of patients who are candidates for Hematopoietic cell transplant (HCT) is crucial to ensure HCT program quality. Continuous knowledge of both a…”
Get full text

Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry by Hernández-Camba, A., Arranz, L., Vera, I., Carpio, D., Calafat, M., Lucendo, A.J., Taxonera, C., Marín, S., Garcia, M.J., Marín, G. Suris, Rodríguez, E. Sánchez, Carbajo, A.Y., De Castro, M.L., Iborra, M., Martin-Cardona, A., Rodríguez-Lago, I., Busquets, D., Bertoletti, F., Ausín, M. Sierra, Tardillo, C., Malaves, J. Huguet, Bujanda, L., Castaño, A., Domènech, E., Ramos, L., Merino, O.

“…Studies to evaluate the use of mycophenolate mofetil (MMF) in inflammatory bowel disease (IBD) are limited after the appearance of biological treatments. Our…”
Get full text

Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic era by NUNES, T, ETCHEVERS, M. J, ESTEVE, M, TAXONERA SAMSO, C, MONTORO HUGUET, M, GISBERT, J. P, MARTIN ARRANZ, M. D, GARCIA-SEPULCRE, M. F, BARREIRO- DE ACOSTA, M, BELTRAN, B, ALCAIDE SUAREZ, N, SARO GISMERA, C, DOMENECH, E, CABRIADA, J. L, CANAS-VENTURA, A, GOMOLLON, F, PANES, J, GARCIA-SANCHEZ, V, BER, Y, PENALVA, M, MERINO, O, NOS, P, GARCIA-PLANELLA, E, CASBAS, A. G

“…Recently, the notion that smoking may adversely affect Crohn's disease (CD) outcomes has been challenged by the suggestion that the widespread use of…”
Get full text

Letter: should colectomy be the end‐point to evaluate the effectiveness of drug therapies in severe ulcerative colitis? by Domènech, E., Gisbert, J. P.

Get full text

Letter: real-life management of new onset ulcerative colitis and proctitis by Domènech, E., Gisbert, J. P.

Get full text

Analysis of the effectiveness of the prophylaxis of vestibular migraine depending on the diagnostic category and the prescribed drug by Domínguez-Durán, E., Montilla-Ibáñez, M. A., Álvarez-Morujo de Sande, M. G., Domènech-Vadillo, E., Bécares-Martínez, C., González-Aguado, R., Guerra-Jiménez, G.

“…Introduction Vestibular migraine (VM) consists of recurrent episodes of vestibular symptoms that are accompanied by migraine in at least 50% of the episodes…”
Get full text